Accepting PhD Students

If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

The goal of the research in our lab is to investigate the genetics and signaling pathways that drive acute myeloid leukemia (AML) to provide a foundation for the development of novel targeted treatment approaches. Our research is focused on identifying the critical mediators of RAS signaling that drive AML growth and survival using molecular genetic approaches in the most clinically relevant genetically engineered mouse models, human AML cell lines, and primary AML patient samples in vitro and in patient-derived AML xenografts. We are evaluating the role of clinically-relevant biochemical signaling pathway inhibitors alone and in combination with novel chemotherapeutic and immunotherapy approaches to maximize the translational potential of our studies. We are utilizing cutting-edge multi-parameter flow cytometry and next generation sequencing to characterize AML treatment response and identify potential mechanisms of treatment resistance. In total, these translational studies will provide novel insights for the development of rationally designed targeted therapies for human AML.


  • targeted cancer therapy
  • immunotherapy
  • acute myeloid leukemia
  • Ras signaling
  • preclincal models

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 3 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Zebrafish Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Embryonic Structures Medicine & Life Sciences
Gene expression Chemical Compounds
Genes Chemical Compounds
Hemangioblasts Medicine & Life Sciences
Danio rerio Agriculture & Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2014

Research Output 2000 2018

A real-world study of clofarabine and cytarabine combination therapy for patients with acute myeloid leukemia

He, F., Sapkota, S., Parker, S., De For, T. E., Warlick, E. D., Ustun, C., Eckfeldt, C. E., Rashidi, A., Kurtzweil, A., Weisdorf, D. J. & Bejanyan, N., Feb 9 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
2 Citations

Allogeneic Hematopoietic Cell Transplantation for Older Patients: Prognosis Determined by Disease Risk Index

He, F., Cao, Q., Lazaryan, A., Brunstein, C., Holtan, S., Warlick, E., Ustun, C., McClune, B., Arora, M., Rashidi, A., Eckfeldt, C., Weisdorf, D. J. & Bejanyan, N., Sep 1 2017, In : Biology of Blood and Marrow Transplantation. 23, 9, p. 1485-1490 6 p.

Research output: Contribution to journalArticle

Cell Transplantation
Hematologic Neoplasms
Confidence Intervals
Treatment Failure

Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia

Pomeroy, E. J., Lee, L. A., Lee, R. D. W., Schirm, D. K., Temiz, N. A., Ma, J., Gruber, T. A., Diaz-Flores, E., Moriarity, B. S., Downing, J. R., Shannon, K. M., Largaespada, D. A. & Eckfeldt, C. E., Jun 8 2017, In : Oncogene. 36, 23, p. 3263-3273 11 p.

Research output: Contribution to journalArticle

ras Genes
Acute Myeloid Leukemia

Successful treatment of two cases of classical Hodgkin lymphoma-associated hemophagocytic lymphohistiocyosis with R-CEPP

Boland, P. J., Hegerova, L., Williams, S. J., McKenna, R. W., Bachanova, V. & Eckfeldt, C. E., Feb 1 2017, In : Leukemia and Lymphoma. 58, 2, p. 478-481 4 p.

Research output: Contribution to journalLetter

Hodgkin Disease
1 Citations

RALB provides critical survival signals downstream of Ras in acute myeloid leukemia

Eckfeldt, C. E., Pomeroy, E. J., Lee, R. D. W., Hazen, K. S., Lee, L. A., Moriarity, B. S. & Largaespada, D. A., Jan 1 2016, In : Oncotarget. 7, 40, p. 65147-65156 10 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Phosphatidylinositol 3-Kinase
Myeloid Cells